154 related articles for article (PubMed ID: 38452155)
1. Analysis of prognosis and background liver disease in non-advanced hepatocellular carcinoma in two decades.
Kaneko S; Asahina Y; Murakawa M; Azuma S; Inada K; Mochida T; Watakabe K; Shimizu T; Tsuchiya J; Miyoshi M; Kawai-Kitahata F; Nitta S; Takahashi M; Fujioka T; Kishino M; Anzai T; Kakinuma S; Nakagawa M; Okamoto R
PLoS One; 2024; 19(3):e0297882. PubMed ID: 38452155
[TBL] [Abstract][Full Text] [Related]
2. Validation and prognostic value of EZ-ALBI score in patients with intermediate-stage hepatocellular carcinoma treated with trans-arterial chemoembolization.
Ananchuensook P; Sriphoosanaphan S; Suksawatamnauy S; Siripon N; Pinjaroen N; Geratikornsupuk N; Kerr SJ; Thanapirom K; Komolmit P
BMC Gastroenterol; 2022 Jun; 22(1):295. PubMed ID: 35701739
[TBL] [Abstract][Full Text] [Related]
3. Cryptogenic hepatocellular carcinoma: characteristics, outcome, and prognostic role of albumin-bilirubin (ALBI) grade vs easy ALBI grade.
Ho SY; Yuan MH; Liu PH; Hsu CY; Huang YH; Liao JI; Su CW; Wang CL; Hou MC; Huo TI
Scand J Gastroenterol; 2023 Jan; 58(1):61-69. PubMed ID: 35830511
[TBL] [Abstract][Full Text] [Related]
4. The value of the Barcelona Clinic Liver Cancer and alpha-fetoprotein in the prognosis of hepatocellular carcinoma.
Gómez-Rodríguez R; Romero-Gutiérrez M; Artaza-Varasa T; González-Frutos C; Ciampi-Dopazo JJ; de-la-Cruz-Pérez G; Sánchez-Ruano JJ
Rev Esp Enferm Dig; 2012 Jun; 104(6):298-304. PubMed ID: 22738699
[TBL] [Abstract][Full Text] [Related]
5. Ascites and alpha-fetoprotein improve prognostic performance of Barcelona Clinic Liver Cancer staging.
Gomaa AI; Al-Khatib A; Abdel-Razek W; Hashim MS; Waked I
World J Gastroenterol; 2015 May; 21(18):5654-62. PubMed ID: 25987792
[TBL] [Abstract][Full Text] [Related]
6. Preoperative albumin-bilirubin grade plus platelet-to-lymphocyte ratio predict the outcomes of patients with BCLC stage A hepatocellular carcinoma after liver resection.
Li C; Zhang XY; Peng W; Wen TF; Yan LN; Li B; Yang JY; Wang WT; Xu MQ; Chen LP
Medicine (Baltimore); 2018 Jul; 97(29):e11599. PubMed ID: 30024565
[TBL] [Abstract][Full Text] [Related]
7. A new ALBI-based model to predict survival after transarterial chemoembolization for BCLC stage B hepatocellular carcinoma.
Lee IC; Hung YW; Liu CA; Lee RC; Su CW; Huo TI; Li CP; Chao Y; Lin HC; Hou MC; Huang YH
Liver Int; 2019 Sep; 39(9):1704-1712. PubMed ID: 31319016
[TBL] [Abstract][Full Text] [Related]
8. Integration of albumin-bilirubin (ALBI) score into Barcelona Clinic Liver Cancer (BCLC) system for hepatocellular carcinoma.
Chan AW; Kumada T; Toyoda H; Tada T; Chong CC; Mo FK; Yeo W; Johnson PJ; Lai PB; Chan AT; To KF; Chan SL
J Gastroenterol Hepatol; 2016 Jul; 31(7):1300-6. PubMed ID: 26751608
[TBL] [Abstract][Full Text] [Related]
9. Applicability of albumin-bilirubin-based Japan integrated staging score in hepatitis B-associated hepatocellular carcinoma.
Chan AW; Chong CC; Mo FK; Wong J; Yeo W; Johnson PJ; Yu S; Lai PB; Chan AT; To KF; Chan SL
J Gastroenterol Hepatol; 2016 Oct; 31(10):1766-1772. PubMed ID: 26992142
[TBL] [Abstract][Full Text] [Related]
10. Tumor burden score-AFP-albumin-bilirubin grade score predicts the survival of patients with hepatocellular carcinoma after liver resection.
Qiu ZC; Li C; Zhang Y; Xie F; Yu Y; Leng SS; Chen TH; Wen TF
Langenbecks Arch Surg; 2023 Jun; 408(1):250. PubMed ID: 37382724
[TBL] [Abstract][Full Text] [Related]
11. Applicability of BALAD score in prognostication of hepatitis B-related hepatocellular carcinoma.
Chan SL; Mo F; Johnson P; Li L; Tang N; Loong H; Chan AW; Koh J; Chan AT; Yeo W
J Gastroenterol Hepatol; 2015 Oct; 30(10):1529-35. PubMed ID: 25968302
[TBL] [Abstract][Full Text] [Related]
12. Value of α-fetoprotein in association with clinicopathological features of hepatocellular carcinoma.
Liu C; Xiao GQ; Yan LN; Li B; Jiang L; Wen TF; Wang WT; Xu MQ; Yang JY
World J Gastroenterol; 2013 Mar; 19(11):1811-9. PubMed ID: 23555170
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of serum microRNA-122 in hepatocellular carcinoma is dependent on coexisting clinical and laboratory factors.
Franck M; Schütte K; Malfertheiner P; Link A
World J Gastroenterol; 2020 Jan; 26(1):86-96. PubMed ID: 31933516
[TBL] [Abstract][Full Text] [Related]
14. Ability of the ALBI grade to predict posthepatectomy liver failure and long-term survival after liver resection for different BCLC stages of HCC.
Zhang ZQ; Xiong L; Zhou JJ; Miao XY; Li QL; Wen Y; Zou H
World J Surg Oncol; 2018 Oct; 16(1):208. PubMed ID: 30326907
[TBL] [Abstract][Full Text] [Related]
15. A comparison of clinical pathologic characteristics between alpha-fetoprotein negative and positive hepatocellular carcinoma patients from Eastern and Southern China.
Chi X; Jiang L; Yuan Y; Huang X; Yang X; Hochwald S; Liu J; Huang H
BMC Gastroenterol; 2022 Apr; 22(1):202. PubMed ID: 35461226
[TBL] [Abstract][Full Text] [Related]
16. Combination of albumin-bilirubin grade and clinically significant portal hypertension predicts the prognosis of patients with hepatocellular carcinoma after liver resection.
Qin L; Li C; Xie F; Wang Z; Wen T
Biosci Trends; 2021 Mar; 15(1):41-49. PubMed ID: 33627573
[TBL] [Abstract][Full Text] [Related]
17. Combination of neutrophil/lymphocyte ratio and albumin/bilirubin grade as a prognostic predictor for hepatocellular carcinoma patients undergoing curative hepatectomy.
Luo H; Huang C; Meng M; Zhang M; Li Z; Huang J
BMC Gastroenterol; 2023 May; 23(1):162. PubMed ID: 37208618
[TBL] [Abstract][Full Text] [Related]
18. Predictors of Micrometastases in Patients with Barcelona Clinic Liver Cancer Classification B Hepatocellular Carcinoma.
Suh SW; Choi YS
Yonsei Med J; 2017 Jul; 58(4):737-742. PubMed ID: 28540985
[TBL] [Abstract][Full Text] [Related]
19. Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification.
Kamiyama T; Orimo T; Wakayama K; Shimada S; Nagatsu A; Yokoo H; Kamachi H; Yamashita K; Shimamura T; Taketomi A
World J Surg Oncol; 2017 Aug; 15(1):156. PubMed ID: 28830473
[TBL] [Abstract][Full Text] [Related]
20. Albumin-bilirubin grade predicts the outcomes of liver resection versus radiofrequency ablation for very early/early stage of hepatocellular carcinoma.
Chong CC; Chan AW; Wong J; Chu CM; Chan SL; Lee KF; Yu SC; To KF; Johnson P; Lai PB
Surgeon; 2018 Jun; 16(3):163-170. PubMed ID: 28807570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
